The North America artificial intelligence in healthcare diagnosis market in North America is expected to grow from US$ 1,716.42 millionin 2019to US$32,009.61 millionby 2027. This represents a CAGR of 44.3%from 2020 to 2027.
The growth of the market in the region is expected to grow owing to rising adoption of Artificial Intelligence (AI) in disease identification and diagnosis, increasing investment in AI healthcare start-ups are projected to drive the North America artificial intelligence in healthcare diagnosismarket during the forecast period.
The US has observed fast growth in the North America artificial intelligence in healthcare diagnosis market within the past few years and is expected to lead the market in North America during the forecast period.The healthcare industry has always been a leader in innovation. The constant mutating of diseases and viruses makes it difficult to stay ahead of the curve. However, with the help of artificial intelligence and machine learning algorithms, it continues to advance, creating new treatments and helping people live longer and healthier. A study published by The Lancet Digital Health compared the performance of deep learning a form of artificial intelligence (AI) in detecting diseases from medical imaging versus that of healthcare professionals, using a sample of studies carried out between 2012 and 2019. The study found that, in the past few years, AI has become more precise in identifying disease diagnosis in these images and has become a more feasible source of diagnostic information. With advancements in AI, deep learning may become even more efficient in identifying diagnosis in the coming years. Moreover, it can help doctors with diagnoses and notify when patients are weakening so that the medical intervention can occur sooner before the patient needs hospitalization. It can save costs for both the hospitals and patients. Additionally, the precision of machine learning can detect diseases such as cancer quickly, thus saving lives.
US Artificial Intelligence in Healthcare Diagnosis Market Revenue and Forecast to 2027 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS – MARKET SEGMENTATION
By Diagnostic Tool
- Medical Imaging Tool
- Automated Detection System
- Others
By Application
- Eye Care
- Oncology
- Radiology
- Cardiovascular
- Others
By Service
- Tele-Consultation
- Tele Monitoring
- Others
By End User
- Hospitals and Clinics
- Diagnostic Laboratory
- Home Care
- Doctors
- Patients
By Country
- US
- Canada
- Mexico
CompanyProfiles
- General Electric Company
- Koninklijke Philips N.V.
- Aidoc, Arterys Inc.
- Icometrix, IDx Technologies Inc.
- MaxQ AI Ltd.
- Caption Health, Inc.
- Zebra Medical Vision, Inc.
- Siemens Healthcare Private Limited
North America Artificial Intelligence in Healthcare Diagnosis Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 1,716.42 Million |
Market Size by 2027 | US$ 32,009.61 Million |
Global CAGR (2020 - 2027) | 44.3% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Diagnostic Tool
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends

















